Neogen (NEOG) Deferred Taxes (2021 - 2026)
Neogen's (NEOG) quarterly Deferred Taxes came in at -$4.3 million in Q1 2026, up 53.47% year-on-year from -$2.8 million in Q1 2025, and up 20.93% quarter-over-quarter from -$5.4 million in Q4 2025.
Neogen (NEOG) Deferred Taxes (2021 - 2026) Analysis & Trends
Neogen's Deferred Taxes history runs 6 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- On a quarterly basis, Deferred Taxes rose 53.47% year-over-year to -$4.3 million in Q1 2026; TTM through Feb 2026 was -$40.2 million, a 33.71% increase from a year earlier, with the FY2025 full-year figure at -$57.8 million, down 110.71% from the prior year.
- Deferred Taxes advanced to -$4.3 million in Q1 2026 per NEOG's latest filing, from -$5.4 million in the prior quarter.
- Across five years, Deferred Taxes topped out at $998000.0 in Q3 2023 and bottomed at -$27.5 million in Q2 2024.
- The 5-year median for Deferred Taxes is -$4.3 million (2026), against an average of -$7.3 million.
- Across the five-year window, Deferred Taxes plunged 9493.33% in 2022 and soared 169.35% in 2023, its largest moves.
- Year by year, Deferred Taxes stood at -$544000.0 in 2022, then surged by 133.09% to $180000.0 in 2023, then sank by 8325.0% to -$14.8 million in 2024, then surged by 63.53% to -$5.4 million in 2025, then gained by 20.93% to -$4.3 million in 2026.
- Per Business Quant, the three latest NEOG Deferred Taxes figures stand at -$4.3 million (Q1 2026), -$5.4 million (Q4 2025), and -$5.8 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -33.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -8.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -9.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 7.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 51.51 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -4.27 Mn |
| Nov 30, 2025 | -5.40 Mn |
| Aug 31, 2025 | -5.83 Mn |
| May 31, 2025 | -24.68 Mn |
| Feb 28, 2025 | -9.18 Mn |
| Nov 30, 2024 | -14.81 Mn |
| Aug 31, 2024 | -9.12 Mn |
| May 31, 2024 | -27.52 Mn |
| Feb 29, 2024 | -1.08 Mn |
| Nov 30, 2023 | 180,000.00 |
| Aug 31, 2023 | 998,000.00 |
| May 31, 2023 | -13.93 Mn |
| Feb 28, 2023 | -3.32 Mn |
| Nov 30, 2022 | -544,000.00 |
| Aug 31, 2022 | -1.44 Mn |
| May 31, 2022 | -3.98 Mn |
| Feb 28, 2022 | -632,000.00 |
| Nov 30, 2021 | -73,000.00 |
| Aug 31, 2021 | -15,000.00 |